Årdal, C.; Lacotte, Y.; Edwards, S.; Ploy, M.-C.; on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI).
National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation. Antibiotics 2021, 10, 749.
https://doi.org/10.3390/antibiotics10060749
AMA Style
Årdal C, Lacotte Y, Edwards S, Ploy M-C, on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI).
National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation. Antibiotics. 2021; 10(6):749.
https://doi.org/10.3390/antibiotics10060749
Chicago/Turabian Style
Årdal, Christine, Yohann Lacotte, Suzanne Edwards, Marie-Cécile Ploy, and on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI).
2021. "National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation" Antibiotics 10, no. 6: 749.
https://doi.org/10.3390/antibiotics10060749
APA Style
Årdal, C., Lacotte, Y., Edwards, S., Ploy, M.-C., & on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI).
(2021). National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation. Antibiotics, 10(6), 749.
https://doi.org/10.3390/antibiotics10060749
